3 completed, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Ursodeoxycholic Acid (UDCA): new trials by email Literature Review of Ursodeoxycholic Acid (UDCA) trials Research Report on Ursodeoxycholic Acid (UDCA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UDCA to Prevent Post-TIPS Hepatic Encephalopathy Ursodeoxycholic Acid (UDCA), Lactulose - Hepatic Encephalopathy (HE), TIPS | Not applicable | Not yet recruiting | West China Hospital | 270 | 2026-01-01 | 2025-12-09 |
| The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia Phototherapy, ursodeoxycholic acid (UDCA) - Hyperbilirubinemia, Neonatal Indirect | Not applicable | Recruiting | Tishreen University Hospital | 70 | 2025-06-26 | 2026-04-21 |
| A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects DWP10292, DWP10292 Placebo, Ursodeoxycholic acid (UDCA) - Healthy | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 58 | 2015-05-01 | 2016-06-02 |
| Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis ursodeoxycholic acid (UDCA) - Primary Sclerosing Cholangitis | Phase 1 | Completed | University of Tennessee | 27 | 2010-10-01 | 2017-10-26 |
| Ursodeoxycholic Acid in Bariatric Surgery Ursodeoxycholic Acid (UDCA) - Non-alcoholic Fatty Liver Disease, Morbid Obesity | Not applicable | Completed | Sahlgrenska University Hospital | 40 | 2008-10-01 | 2013-12-03 |
Cholangitis, Sclerosing (1) · Fibrosis (1) · Glucosephosphate Dehydrogenase Deficiency (1) · Hepatic Encephalopathy (1) · Hepatitis, Autoimmune (1) · Hyperbilirubinemia, Neonatal (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity, Morbid (1)
Daewoong Pharmaceutical Co. LTD. (1) · Sahlgrenska University Hospital (1) · Tishreen University Hospital (1) · University of Tennessee (1) · West China Hospital (1)
China (1) · Syria (1) · United States (1)
Adnan H Dayoub, Prof.Neonat (1) · Benjamin Shneider, M.D. (1) · Dennis D Black, M.D. (1) · Hanns-Ulrich Marschall, MD, PhD (1)
PMID 25316553, PMID 28853202, PMID 31534356, PMID 33621635, PMID 33682983, PMID 35289658, PMID 37178732, PMID 37606572, PMID 38349709, PMID 38492132, PMID 39181214, PMID 39565434, PMID 39864468, PMID 39962750